People / SEC CIK 0001855684

Ajim Tamboli

Career history and related SEC filings

Career history

  1. First Tracks Biotherapeutics

    Chief Financial Officer

    Board appointment Apr 17, 2026. Effective Apr 20, 2026.

  2. ADARx Pharmaceuticals

    Chief Financial Officer

  3. Arbor Biotechnologies

    Chief Financial Officer

  4. Rodin Therapeutics

    Chief Financial Officer

Related filing events

Browse linked events from SEC filings within FilingRelay's coverage.

0 events

No events for this selection

Try another company, event type, or filing period.